spacer
home > pmps > summer 2017 > factory of the future
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Factory of the Future

Despite strict administrative regulations, the pharmaceutical sector is an increasingly competitive marketplace where established industry giants are vying against providers of cheaper, generic alternatives. Meanwhile, new companies – formed through merger and acquisition activities – are approaching the field.

Existing players are under increasing pressure. Delivering the highest quality products and accurate information on packaging is now more critical than ever before. Medications need to not only appeal to the consumer with clear guidelines on safe use, ingredients and side effects, but must also be compliant with the rigorous stateimposed standards.

Every package must contain accurate data and clear labelling before it can be distributed to healthcare and pharma organisations en masse. Given the unique regulations surrounding the sale of therapeutics and similar medical products compared to other goods, drug developers are required to take special care on their production lines, while keeping operational costs low.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Eva Weber, Senior Product Marketing Manager for SDKs, is responsible for product marketing activities for ABBYY Europe’s technology licensing products. With her extensive expertise, Eva is a key driver of the company's activities around the usage of OCR within the machine vision industry, including educational webinars and press articles. 
spacer
Eva Weber
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

TP3 global presents innovative thermal protection at cool chain 2018 london, uk

TP3 Global, a leading supplier of thermal packaging solutions for the pharmaceutical industry, is to showcase its newly-released range of thermal covers at the 17th annual Cool Chain conference in January 2018.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

4th Annual Formulation & Drug Delivery Congress

8-9 May 2018, London, UK

Oxford Global are proud to present our hugely popular 4th Annual Formulation & Drug Delivery Congress, 8th – 9th May 2018, London, UK.Over 300 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions will gather for over 40 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement